Marco Mor Selected Research

Cytokines

1/2020

FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Mor Research Topics

Disease

26	Neoplasms (Cancer) 02/2022 - 11/2011
16	Pain (Aches) 12/2021 - 06/2005
9	Inflammation (Inflammations) 12/2021 - 12/2009
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 03/2010
6	Body Weight (Weight, Body) 01/2020 - 08/2006
6	Lung Neoplasms (Lung Cancer) 01/2019 - 02/2008
3	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2015 - 01/2008
2	Multiple Myeloma 01/2020 - 01/2016
2	Osteoarthritis 01/2020 - 01/2015
2	Neoplasm Metastasis (Metastasis) 12/2018 - 01/2016
2	Necrosis 09/2017 - 01/2003
2	Prostatic Neoplasms (Prostate Cancer) 10/2013 - 06/2012
2	Carcinogenesis 10/2013 - 06/2012
2	Hyperalgesia 09/2013 - 03/2013
2	Catalepsy 02/2013 - 01/2006
2	Sleep Wake Disorders 12/2011 - 01/2008
1	Chronic Pain 10/2021
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 02/2020
1	Joint Diseases (Joint Disease) 01/2020
1	Anhedonia 01/2020
1	Carcinoma (Carcinomatosis) 12/2019
1	Monosomy 09/2019
1	Uveal melanoma 09/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Glaucoma 01/2018
1	Melanoma (Melanoma, Malignant) 09/2017
1	Breast Neoplasms (Breast Cancer) 09/2017
1	Pathologic Processes 05/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016

Drug/Important Bio-Agent (IBA)

6	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2018 - 09/2005
5	AcidsIBA 10/2021 - 12/2009
5	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021 - 08/2015
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 02/2008
5	Gefitinib (Iressa)FDA Link 01/2019 - 07/2010
5	ErbB Receptors (EGF Receptor)IBA 03/2015 - 07/2010
4	N-acylethanolaminesIBA 10/2021 - 12/2009
4	EnzymesIBA 10/2021 - 11/2011
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021 - 03/2013
4	amidaseIBA 10/2021 - 12/2009
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021 - 08/2015
4	heparanaseIBA 12/2020 - 01/2016
4	EndocannabinoidsIBA 05/2016 - 07/2007
4	LigandsIBA 01/2016 - 06/2012
4	anandamide (arachidonylethanolamide)IBA 12/2015 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2013
3	LipidsIBA 10/2021 - 08/2006
3	Pharmaceutical PreparationsIBA 02/2020 - 07/2007
3	EphrinsIBA 02/2020 - 06/2012
3	CannabinoidsIBA 01/2020 - 01/2006
3	SolutionsIBA 01/2019 - 09/2009
3	Biological ProductsIBA 01/2018 - 11/2015
3	Melatonin Receptors (Melatonin Receptor)IBA 01/2018 - 01/2008
3	ramelteon (Rozerem)FDA Link 07/2015 - 01/2008
3	Analgesics (Analgesic Drugs)IBA 11/2011 - 07/2007
3	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 09/2009 - 07/2007
2	AntioxidantsIBA 01/2020 - 09/2017
2	URB937IBA 12/2019 - 10/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 08/2015
2	Lithocholic AcidIBA 01/2016 - 04/2013
2	CarbamatesIBA 01/2016 - 09/2009
2	Sucrose (Saccharose)IBA 11/2015 - 11/2007
2	EphA2 ReceptorIBA 09/2015 - 06/2012
2	palmidrolIBA 08/2015 - 12/2009
2	oleoylethanolamideIBA 08/2015 - 08/2006
2	Adenosine Triphosphate (ATP)IBA 03/2015 - 03/2010
2	cholanic acidIBA 10/2013 - 06/2012
2	5-phenylpentyl N- ((2S,3R)- 2- methyl- 4- oxo- oxetan- 3- yl)carbamateIBA 09/2013 - 03/2013
2	Phosphotransferases (Kinase)IBA 01/2013 - 11/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2012 - 07/2010
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2011 - 10/2010
2	PPAR alphaIBA 12/2009 - 08/2006
1	Transcription Factors (Transcription Factor)IBA 02/2022
1	osimertinibIBA 12/2021
1	Therapeutic UsesIBA 12/2021
1	CatalaseIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Iodoacetic AcidIBA 01/2020
1	CytokinesIBA 01/2020
1	Vitamin E FDA LinkGeneric 01/2020
1	CorticosteroneIBA 01/2020
1	erdafitinibIBA 12/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	chloroacetamideIBA 01/2019
1	Thymidylate SynthaseIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Proline (L-Proline)FDA Link 01/2018
1	MelatoninIBA 09/2017
1	sulforaphaneIBA 07/2016
1	Serine (L-Serine)FDA Link 05/2016
1	Monoacylglycerol LipasesIBA 05/2016
1	HydrolasesIBA 05/2016
1	AnticoagulantsIBA 01/2016
1	SteroidsIBA 01/2016
1	roneparstatIBA 01/2016
1	SST 0001IBA 01/2016

Therapy/Procedure

9	Therapeutics 10/2021 - 10/2010
2	Oral Administration 12/2019 - 07/2007
2	Topical Administration 09/2013 - 03/2013